What's Happening?
Representative Rick Larsen has introduced H.R. 11035, titled the 'Closing the Substance Use Care Gap Act of 2026.' This proposed legislation aims to establish a new federal grant program designed to support community-based harm reduction services for
individuals who use drugs or have substance use disorder. The bill, introduced on November 13, 2026, currently has no cosponsors. Under this program, the Secretary of Health and Human Services, in collaboration with the Assistant Secretary for Mental Health and Substance Use and the CDC, would award grants to eligible entities. These entities include state, local, tribal, and territorial governments, tribal organizations, community-based harm reduction programs (including syringe services programs), primary and behavioral health organizations, and opioid treatment programs. Grant funds could be utilized for various services, such as preventing infectious diseases linked to substance use, overdose prevention efforts (including distributing opioid overdose reversal medication), connecting individuals to treatment and recovery support, and establishing referral systems to evidence-based services. The bill authorizes $30 million annually for fiscal years 2027 through 2031, with a small percentage allocated for administrative costs and technical assistance.
Why It's Important?
This bill is significant as it addresses the ongoing public health crisis of substance use disorder by proposing a direct federal funding mechanism for harm reduction strategies. Harm reduction approaches are increasingly recognized as crucial components of a comprehensive public health response, aiming to minimize the negative health, social, and economic consequences associated with drug use. By supporting community-based programs, the legislation seeks to reach vulnerable populations directly, potentially reducing overdose deaths, preventing the spread of infectious diseases like HIV and hepatitis, and facilitating pathways to treatment and recovery. The allocation of $30 million per year signifies a substantial federal commitment to these services, which could lead to a more standardized and accessible network of support across the nation. This initiative could also alleviate pressure on emergency services and healthcare systems by focusing on prevention and early intervention within communities. The bill's emphasis on evidence-based practices and reporting requirements aims to ensure accountability and effectiveness in the use of federal funds.
What's Next?
Following its introduction, H.R. 11035 will proceed through the legislative process, which typically involves committee review, potential amendments, and votes in both the House of Representatives and the Senate. The bill's progress will depend on gaining bipartisan support and navigating congressional priorities. Should it advance, the Secretary of Health and Human Services would be responsible for developing guidelines for grant applications, establishing oversight mechanisms, and providing technical assistance to grantees. The bill also mandates regular reports to Congress on the impact of the grants, which will be crucial for evaluating the program's effectiveness and informing future policy decisions. Stakeholders, including public health organizations, addiction treatment providers, and community advocacy groups, will likely monitor the bill's progress closely and may engage in advocacy efforts to support its passage. The authorization of funding from fiscal years 2027 through 2031 indicates a long-term vision for federal support in this area, suggesting that if passed, the program would have a sustained impact.
Beyond the Headlines
The introduction of H.R. 11035 reflects a broader shift in public health policy towards embracing harm reduction as a legitimate and effective strategy in addressing substance use. Historically, approaches to drug use have often focused solely on abstinence or punitive measures. However, growing evidence supports the efficacy of harm reduction in saving lives and improving public health outcomes. This bill could further normalize and integrate harm reduction services into the mainstream healthcare system, potentially reducing stigma associated with drug use and encouraging more individuals to seek help. Ethically, it underscores a public health philosophy that prioritizes the well-being and safety of individuals who use drugs, recognizing their inherent dignity and right to health services. Legally, if enacted, it would establish a federal framework for funding these services, potentially influencing state and local policies and funding priorities. The long-term implications could include a more compassionate and effective national response to the opioid crisis and other substance use challenges, fostering healthier communities and reducing the societal burden of addiction.













